fda warning bpc-157 not approved safety risks is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, companies they can't market them as equivalent to drugs and signaling stronger enforcement to protect patients from unverified FDA scientists flag concerns with

Lab Tests Might Say Normal, But Your Body Might Say Otherwise Its incredibly common to hear someone say their B12 levels are fine according to a lab test, yet they still feel completely drained

doi: 10.4103/1673-5374.293145

The evidence is modest

Men exploring peptide therapy for GH optimization often have overlapping concerns about testosterone, and the two systems interact meaningfully: testosterone supports lean mass and anabolic signaling, while GH and IGF-1 support fat metabolism, recovery, and tissue repair through distinct but complementary pathways

Its effect was associated with a significant decrease in oxidative stress parameters and likely maintained NO system function, providing that BPC 157 interacted with eNOS and COX2 gene expression, in a particular way and counteracted the noxious effect of the NOS-blocker, L-NAME

It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models